Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from GSK

GSK Surges After Settling First Zantac Case, But A 'Conveyor Belt' Of Claims Looms

GSK stock jumped Friday after the British drugmaker said it settled one of thousands of claims that its heartburn drug Zantac caused cancer.

Investors Business Daily

How big pharma is using AI to untangle the language of DNA

AI-powered tools are rapidly transforming the world of drug discovery

Evening Standard

GSK settles lawsuit over heartburn drug allegedly linked to cancer

The drug was owned by GSK but distribution was halted and it was recalled in 2019

Wales Online

From analysis to the latest developments in health,
read the most diverse news in one place.

A+E Works With Ad Client GSK To Produce Meningitis B Awareness Film

Short features Soleil Moon Frye, Melissa Joan Hart

Multichannel News

Vivek Ramaswamy is threatening GOP heavyweights in the polls–but his business record doesn't live up to the hype

Yale's Sonnenfeld and Tian retrace presidential hopeful Vivek Ramaswamy's business record.

Fortune

GSK CEO Emma Walmsley says A.I. could improve Big Pharma's most 'profound' challenge: R&D inefficiency

"When we talk about health care costs, the single biggest thing we can do is innovate more.”

Fortune

GSK’s CEO says you need thick skin if you’re going to step into the C-suite

Emma Walmsley reflects on what it takes to lead a company through a turnaround.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Why GSK's Emma Walmsley 'violently rejects' the idea of 'superhero' CEOs

In her mind, leadership is about inspiring collaboration.

Fortune

Being 'nature-positive' has been a hollow aim. That’s about to change

Move over, greenwashing (and greenwishing). Goodbye, vague nature goals. Enter science-based nature targets.

Fortune

Giant turbines in South Ayrshire village would power Irvine pharmaceutical giant's factory

Residents debated whether to pragmatically embrace two turbines, which would power nearby GSK, planned for Dundonald.

Daily Record

RSV vaccine for pregnant women protects their newborns but is it ready for US sale?

Federal health advisers are debating a first-of-its-kind RSV vaccine to protect newborns by immunizing their moms late in pregnancy

The Independent UK

Concerned About Recession? Morningstar Has Stock Ideas. (Anheuser Is One.)

These are companies whose products consumers will keep buying in any economic climate, Morningstar says.

The Street

AI Drug Discovery Is a $50 Billion Opportunity for Big Pharma

Artificial intelligence can shave years off the development process, and companies like Japan’s Takeda are making large investments.

Businessweek

FDA approves first vaccine for respiratory syncytial virus

The FDA has approved the first vaccine for respiratory syncytial virus (RSV).

The Hindu

Get all your
news in one place.

100’s of premium titles.
One news app.

Chicago Sun-Times

FDA approves 1st RSV vaccine for older adults

After decades of failure in the quest for an RSV vaccine, doctors are anxious to finally have something to offer — especially after a virus surge that strained hospitals last fall.

LiveScience

FDA approves 1st RSV vaccine

The Food and Drug Administration has approved a vaccine for respiratory syncytial virus (RSV) for use in people ages 60 and older.

Axios

FDA approves United States' first-ever RSV vaccine

GSK's RSV vaccine is approved for people aged 60 and older.

Investors Business Daily

GSK Stock Jumps After Beating Pfizer, Moderna To The RSV Vaccine Finish Line

GSK stock jumped Wednesday after the drugmaker won the first-ever approval for an RSV vaccine, leading rivals Pfizer and Moderna.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

US approves first vaccine for RSV after decades of attempts

The US has approved the first vaccine for RSV, shots to protect older adults

Investors Business Daily

Drug Heavyweights GSK, Roche Topple As Covid Weighs On Sales Growth

GSK leaned on vaccines while Roche relied on pharmaceutical sales to outplay Covid declines. But shares of both fell Tuesday.

The Guardian - UK

New CBI boss says she is ‘profoundly sorry’ to women let down by group

Rain Newton-Smith’s tweets came on day she became director general at Confederation of British Industry

Evening Standard

End of the road for Covid turnover, GSK says

GSK has signalled the end of the road for its Covid drug sales boom as the pharma giant eyes fresh sources of revenue to plug the hole left by the subsidence of the pandemic.

Evening Standard

FTSE 100 Live: ‘A radical decline in UK investment’ — London Stock Exchange boss grilled on US listings

GSK, housebuilder Persimmon and the consumer products group Reckitt Benckiser are among the blue-chips updating investors today.

The Guardian - UK

AstraZeneca overtakes Pfizer as crunch week for UK pharma looms

Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results

Insider UK

GSK workers to strike after rejecting pay offer

Workers at sites in Irvine and Montrose are set to walk out next month

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

the London Stock Exchange

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.